Evaluation of the triiodothyronine suppression test in the treatment of Graves' disease.
D000293:Adolescent; D000328:Adult; D000368:Aged; D013956:Antithyroid Agents / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006042:Goiter / Q000188:drug therapy; D006111:Graves Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D008297:Male; D008713:Methimazole / Q000627:therapeutic use; D008875:Middle Aged; D011877:Radionuclide Imaging; D013960:Thyroid Function Tests; D013965:Thyroidectomy; D014284:Triiodothyronine / Q000627:therapeutic use
D013956:Antithyroid Agents; D014284:Triiodothyronine; D008713:Methimazole